Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Feasibility and Safety of Walking Football in Patients With Type 2 Diabetes

20 augustus 2019 bijgewerkt door: Romeu Mendes, Universidade do Porto
Our main challenge is to develop a novel physical activity intervention to promote exercise participation sustainability and effective health benefits in type 2 diabetes (T2D) population with minimum health risks. The relevance of this study is supported by four cornerstones: 1) The Portuguese love football and there seems to be a major potential in the implementation of football practice as part of the prevention and treatment of noncommunicable diseases for the middle-aged and elderly Portuguese population; 2) no studies have assessed the feasibility and safety of a walking football exercise program for middle-age and older patients with T2D; 3) the proposed investigation relies on robust methodology; 4) this intervention can have further sustainability with the enrollment of football clubs and primary health care units.

Studie Overzicht

Toestand

Voltooid

Gedetailleerde beschrijving

This work will be a quasi-experimental study where we aim to test the feasibility and safety of walking football in patients with T2D. The recruitment of participants will be held in primary health care units by Family Medicine medical doctors. All participants will receive instructions to maintain daily-life routines (lifestyle-related physical activity and dietary pattern), and to continue with usual care (diabetes consultations on primary health care units and pharmacological regimen) along the studies duration. All participants will receive basic sports material (sports bag, T-shirt, and sports shoes). Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety (acute effects on capillary glycaemia, blood pressure, foot impact, exercise-related injuries and adverse events) and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Cumulative short-term effects will also be analyzed along the three months through pre- and post-study evaluations. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

40

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

      • Porto, Portugal, 4050-600
        • Instituto de Saúde Pública da Universidade do Porto

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

50 jaar tot 70 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Mannelijk

Beschrijving

Inclusion Criteria:

  • diagnosis of type 2 diabetes for at least 12 months;
  • glycated hemoglobin bellow 10 %;
  • not having started insulin therapy in the previous six months;
  • not having started therapy with sulfonylureas in the previous six months;
  • major complications of diabetes screened and controlled (diabetic retinopathy, diabetic nephropathy and diabetic foot);
  • no symptoms of coronary artery disease;
  • no cardiovascular, respiratory and musculoskeletal contraindications to exercise;
  • not under cancer treatment (radiotherapy or intravenous chemotherapy);
  • without limitations in gait or balance;
  • independent living in the community;
  • not engaged in supervised exercise;
  • non-smokers at least for 6 months.

Exclusion Criteria:

  • cardiological stress test with cardiac or hemodynamic problems

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: NVT
  • Interventioneel model: Opdracht voor een enkele groep
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Exercise
Walking football exercise program
Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Exercise intensity - subjective internal load
Tijdsspanne: Through 3 months
OMNI rating of perceived exertion scale during exercise (0 [lowest] to 10 [highest] points)
Through 3 months
Exercise intensity - objective internal load
Tijdsspanne: Through 3 months
Heart rate during exercise
Through 3 months
Exercise intensity - external load
Tijdsspanne: Through 3 months
Distance (km) assessed using GPS tracking during exercise
Through 3 months
Acute glycemic effect
Tijdsspanne: Change between before and immediately after each exercise session
Acute change in capillary blood glucose with exercise sessions
Change between before and immediately after each exercise session
Acute systolic blood pressure effect
Tijdsspanne: Change between before and immediately after each exercise session
Acute change in systolic blood pressure with exercise sessions
Change between before and immediately after each exercise session
Acute diastolic blood pressure effect
Tijdsspanne: Change between before and immediately after each exercise session
Acute change in diastolic blood pressure with exercise sessions
Change between before and immediately after each exercise session
Incidence of falls
Tijdsspanne: Through 3 months
Number of falls during the exercise program
Through 3 months
Incidence of foot injuries
Tijdsspanne: Through 3 months
Number of reported foot injuries during the exercise program
Through 3 months
Incidence of musculoskeletal injuries
Tijdsspanne: Through 3 months
Number of reported musculoskeletal injuries during the exercise program
Through 3 months
Rate of Enjoyment
Tijdsspanne: Through 3 months
Self-reported exercise sessions' enjoyment on a likert scale (1 [lowest] to 5 [highest] points)
Through 3 months

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Glycemic control
Tijdsspanne: Change from baseline to 3 months
Glycated hemoglobin (venous blood analysis)
Change from baseline to 3 months
Blood lipid profile
Tijdsspanne: Change from baseline to 3 months
Total cholesterol (venous blood analysis)
Change from baseline to 3 months
Clinical systolic blood pressure
Tijdsspanne: Change from baseline to 3 months
Resting systolic blood pressure
Change from baseline to 3 months
Clinical diastolic blood pressure
Tijdsspanne: Change from baseline to 3 months
Resting diastolic blood pressure
Change from baseline to 3 months
Body mass index
Tijdsspanne: Change from baseline to 3 months
Body mass index
Change from baseline to 3 months
Waist circumference
Tijdsspanne: Change from baseline to 3 months
Waist circumference
Change from baseline to 3 months
Body fat
Tijdsspanne: Change from baseline to 3 months
Body fat (bioelectrical impedance analysis)
Change from baseline to 3 months
Body lean mass
Tijdsspanne: Change from baseline to 3 months
Body lean mass (bioelectrical impedance analysis)
Change from baseline to 3 months
Agility/balance
Tijdsspanne: Change from baseline to 3 months
Timed Up and Go Test
Change from baseline to 3 months
Habitual physical activity
Tijdsspanne: Change from baseline to 3 months
Global Physical Activity Questionnaire
Change from baseline to 3 months
Food pattern
Tijdsspanne: Change from baseline to 3 months
24h-food recall analysis
Change from baseline to 3 months
Cognitive state
Tijdsspanne: Change from baseline to 3 months
Montreal Cognitive Assessment score (0 [lowest] to 30 [highest] points)
Change from baseline to 3 months
Health-related quality of life
Tijdsspanne: Change from baseline to 3 months
EQ-5D-5L questionnaire score (0 [lowest] to 100 [highest] points)
Change from baseline to 3 months
Medication
Tijdsspanne: Change from baseline to 3 months
Number of medications
Change from baseline to 3 months

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Romeu Mendes, MD, PhD, EPIUnit - Instituto de Saúde Pública, Universidade do Porto

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

  • Barbosa A, Brito J, Costa J, Ramos E, Firmino-Machado J, Seabra A, Figueiredo P, Sá MJ, Lunet N, Mendes R. SWEET-FOOTBALL: Development of an evidence-based walking football program for middle-aged and older patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern Denmark; 2019. p. 32.
  • Barbosa A, Brito J, Sá MJ, Puga F, Firmino-Machado J, Seabra A, Figueiredo P, Ramos E, Lunet N, Mendes R. Adherence and enjoyment of a walking-football program for patients with type 2 diabetes: SWEET-FOOTBALL Project. In: Bunc V, Tsolakidis E, editors. Book of Abstracts of the 24th Annual Congress of the European College of Sport Science. Prague: ECSS; 2019. p. 120-1.
  • Rago V, Brito J, Costa J, Barbosa A, Figueiredo P, Seabra A, Travassos B, Mendes R. Activity profile during walking football training sessions in patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern University; 2019. p. 41.
  • Costa J, Brito J, Barbosa A, Figueiredo P, Seabra A, Sá MJ, Firmino-Machado J, Ramos E, Mendes R. Nocturnal cardiac autonomic activity in patients with type 2 diabetes engaged in a walking football programme. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern Denmark; 2019. p. 39.
  • Barbosa A, Brito J, Costa J, Figueiredo P, Seabra A, Mendes R. Feasibility and safety of a walking football program in middle-aged and older men with type 2 diabetes. Prog Cardiovasc Dis. 2020 Nov-Dec;63(6):786-791. doi: 10.1016/j.pcad.2020.06.014. Epub 2020 Jul 4.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

17 september 2018

Primaire voltooiing (Werkelijk)

31 januari 2019

Studie voltooiing (Werkelijk)

30 juni 2019

Studieregistratiedata

Eerst ingediend

10 januari 2019

Eerst ingediend dat voldeed aan de QC-criteria

16 januari 2019

Eerst geplaatst (Werkelijk)

22 januari 2019

Updates van studierecords

Laatste update geplaatst (Werkelijk)

22 augustus 2019

Laatste update ingediend die voldeed aan QC-criteria

20 augustus 2019

Laatst geverifieerd

1 augustus 2019

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren